Phase
Condition
Breast Cancer
Metastatic Cancer
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosed with de novo or recurrent advanced breast cancer since 2007
Diagnosed with or treated for advanced breast cancer in one of the participatinghospitals
Participating hospitals (period of inclusion): Maastricht UMC+ (2007-2025),Zuyderland hospitals Sittard/Heerlen (2007-2025), Amphia Hospital Breda (2013-2025),Catharina Hospital Eindhoven (2007-2025), Elkerliek Hospital Helmond (2010-2025),Maxima Medical Center Veldhoven/Eindhoven (2007-2025), Jeroen Bosch Hospital DenBosch (2013-2025), Laurentius Hospital Roermond (2007-2025), St. AnnaziekenhuisGeldrop (2007-2025), St. Elisabeth Hospital Tilburg (2007-2009), St. Jans GasthuisWeert (2007-2025), VieCuri Medical Center Venlo/Venray (2013-2025), all in theNetherlands.
Hospitals (and periods) were eligible for inclusion if (distant) registration fromMaastricht UMC+ was possible.
The inclusion period may be prolonged after 2025.
Exclusion
Exclusion Criteria: none
Study Design
Study Description
Connect with a study center
Multiple hospitals in the Netherlands (see Eligibility)
Maastricht,
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.